JP4706636B2 - 鎮痛剤 - Google Patents

鎮痛剤 Download PDF

Info

Publication number
JP4706636B2
JP4706636B2 JP2006542444A JP2006542444A JP4706636B2 JP 4706636 B2 JP4706636 B2 JP 4706636B2 JP 2006542444 A JP2006542444 A JP 2006542444A JP 2006542444 A JP2006542444 A JP 2006542444A JP 4706636 B2 JP4706636 B2 JP 4706636B2
Authority
JP
Japan
Prior art keywords
pain
analgesic
compound
cyclopropylmethyl
morphinan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2006542444A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2006049248A1 (ja
Inventor
直樹 泉本
邦昭 川村
俊和 駒形
忠俊 橋本
長袋　　洋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2006542444A priority Critical patent/JP4706636B2/ja
Publication of JPWO2006049248A1 publication Critical patent/JPWO2006049248A1/ja
Application granted granted Critical
Publication of JP4706636B2 publication Critical patent/JP4706636B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2006542444A 2004-11-04 2005-11-04 鎮痛剤 Expired - Fee Related JP4706636B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006542444A JP4706636B2 (ja) 2004-11-04 2005-11-04 鎮痛剤

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004320583 2004-11-04
JP2004320583 2004-11-04
JP2006542444A JP4706636B2 (ja) 2004-11-04 2005-11-04 鎮痛剤
PCT/JP2005/020297 WO2006049248A1 (ja) 2004-11-04 2005-11-04 鎮痛剤

Publications (2)

Publication Number Publication Date
JPWO2006049248A1 JPWO2006049248A1 (ja) 2008-08-07
JP4706636B2 true JP4706636B2 (ja) 2011-06-22

Family

ID=36319248

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006542444A Expired - Fee Related JP4706636B2 (ja) 2004-11-04 2005-11-04 鎮痛剤

Country Status (12)

Country Link
US (1) US8470845B2 (https=)
EP (1) EP1820505A4 (https=)
JP (1) JP4706636B2 (https=)
KR (1) KR101285645B1 (https=)
CN (1) CN101090722B (https=)
AR (1) AR053098A1 (https=)
CA (1) CA2586181C (https=)
MX (1) MX2007005336A (https=)
NO (1) NO20072832L (https=)
PE (1) PE20060723A1 (https=)
TW (1) TW200621785A (https=)
WO (1) WO2006049248A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324742B2 (en) 2018-03-08 2022-05-10 Victoria Link Ltd. Treatment of demyelinating diseases

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2464593T3 (es) * 2005-11-09 2014-06-03 Toray Industries, Inc. Agente terapéutico o profiláctico para trastornos funcionales digestivos
CA2634055C (en) * 2005-12-21 2011-07-05 Toray Industries, Inc. Antitussive agent
FR2902341B1 (fr) 2006-06-16 2011-02-25 Scras Utilisation therapeutique simultanee, separee ou etalee dans le temps d'au moins une neurotoxine botulique, et d'au moins un derive opiace
FR2910327B1 (fr) 2006-12-22 2013-04-26 Scras Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida.
ES2627217T3 (es) * 2007-05-21 2017-07-27 Toray Industries, Inc. Partículas micropulverizadas cristalinas
AU2008254039B2 (en) * 2007-05-21 2013-10-24 Toray Industries, Inc. Method for producing pharmaceutical tablet
US9084817B2 (en) * 2007-05-21 2015-07-21 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
FR2930447B1 (fr) 2008-04-25 2010-07-30 Sod Conseils Rech Applic Utilisation therapeutique d'au moins une neurotoxine botulique dans le traitement de la douleur dans le cas de la neuropathie diabetique

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (https=) * 1964-02-03 1966-10-31
JPH11501627A (ja) * 1995-03-03 1999-02-09 アルゴス ファーマシューティカル コーポレーション 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体
JP2004522706A (ja) * 2000-10-31 2004-07-29 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318885A (en) 1965-07-21 1967-05-09 American Cyanamid Co Substituted 6-amino-6, 14-endoethen-ocodides and morphides
NL8102558A (nl) * 1981-05-25 1982-12-16 Alcoa Nederland Bv Lichtmast met versterking van de opening in het onderste gedeelte.
KR970011390B1 (ko) * 1992-01-23 1997-07-10 도레이 가부시키가이샤 모르피난 유도체와 약리학적으로 허용되는 이의 산 부가염 및 이를 함유하는 약제학적 조성물
AU686203B2 (en) 1993-07-23 1998-02-05 Toray Industries, Inc. Morphinan derivative and medicinal use
CN1374963A (zh) 1999-07-19 2002-10-16 东丽株式会社 尿频或尿失禁的治疗或预防剂
DE19939044A1 (de) * 1999-08-18 2001-03-15 Gruenenthal Gmbh Verwendung von Morphinanderivaten als Arzneimittel
JP4118824B2 (ja) 2004-02-24 2008-07-16 株式会社日立製作所 優先パケットの遅延を最小化するシェーピング装置
JP4118826B2 (ja) 2004-03-01 2008-07-16 リオン株式会社 補聴器用ケースなどの製造方法及びその装置
JP4882744B2 (ja) 2004-03-30 2012-02-22 東レ株式会社 止痒剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4118823B1 (https=) * 1964-02-03 1966-10-31
JPH11501627A (ja) * 1995-03-03 1999-02-09 アルゴス ファーマシューティカル コーポレーション 尿失禁の治療用のデキシトルメトルファン又はデキシトルオルファンの使用
JP2004522706A (ja) * 2000-10-31 2004-07-29 レンセラール ポリテクニック インスティチュート ８−カルボキサミド−２，６−メタノ−３−ベンズアゾシン
WO2004033457A1 (ja) * 2002-10-09 2004-04-22 Toray Industries, Inc. 頻尿もしくは尿失禁の治療または予防剤および含窒素環状置換基を有するモルヒナン誘導体

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11324742B2 (en) 2018-03-08 2022-05-10 Victoria Link Ltd. Treatment of demyelinating diseases
US12318380B2 (en) 2018-03-08 2025-06-03 Victoria Link Ltd. Treatment of demyelinating diseases

Also Published As

Publication number Publication date
CA2586181A1 (en) 2006-05-11
JPWO2006049248A1 (ja) 2008-08-07
TWI356826B (https=) 2012-01-21
HK1115808A1 (en) 2008-12-12
AR053098A1 (es) 2007-04-25
TW200621785A (en) 2006-07-01
CA2586181C (en) 2012-11-27
US8470845B2 (en) 2013-06-25
PE20060723A1 (es) 2006-08-29
NO20072832L (no) 2007-08-01
EP1820505A4 (en) 2010-01-20
EP1820505A1 (en) 2007-08-22
MX2007005336A (es) 2007-06-25
KR20070085436A (ko) 2007-08-27
KR101285645B1 (ko) 2013-07-12
CN101090722B (zh) 2011-12-21
WO2006049248A1 (ja) 2006-05-11
CN101090722A (zh) 2007-12-19
US20070299100A1 (en) 2007-12-27

Similar Documents

Publication Publication Date Title
US6174891B1 (en) Antipruritic agent
KR101855357B1 (ko) 오피오이드 유도성 통각과민에서의 시그마 리간드의 용도
RU2559888C2 (ru) Аналоги этомидата, которые не ингибируют синтез адренокортикостероидов
JP5860895B2 (ja) ５−メチル−１−（ナフタレン−２−イル）−１ｈ−ピラゾール誘導体
JPH11510828A (ja) 光学的に純粋な（＋）ノルシサプリドを用いた嘔吐および中枢神経系障害の治療方法
CN102711759B (zh) 胆道疾病的治疗或预防药
JP4706636B2 (ja) 鎮痛剤
JP4867123B2 (ja) 神経因性疼痛治療剤および神経因性疼痛のモデル動物
WO2006079559A2 (en) The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
JPWO2001014383A1 (ja) 神経因性疼痛治療剤および神経因性疼痛のモデル動物
ES2307025T3 (es) Combinacion de opioides y un derivado de la piperazina para el tratamiento del dolor.
AU689577B2 (en) New combination of a beta -receptor blocker and a local anaesthetic
US6440987B1 (en) Antipruritic
JP2015520145A (ja) 呼吸抑制の治療
WO2019100057A1 (en) Use of morphinans for treating cocaine addiction, pruritis, and seizure disorders
CA2970256C (en) Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
HK1115808B (en) Analgesic
CN1107333A (zh) 那布扶林镇痛剂的长效前体药物及其制备方法
WO2016099394A1 (en) Novel selective delta-opioid receptor agonists useful for the treatment of pain, anxiety and depression.
JP3531170B6 (ja) 止痒剤
WO1996031472A1 (en) Novel heterocyclic compounds
HK1098679A (en) Anti-itching agent

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101029

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110215

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110228

R151 Written notification of patent or utility model registration

Ref document number: 4706636

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

LAPS Cancellation because of no payment of annual fees